Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-31

FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Alprazolam from Sandoz Inc, confirming approval of a generic Alprazolam product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)